ITAT: Assessee can plead exclusion of comparables included in TP study report; Follows Pfizer

Dec 14, 2023
|

Simply Register/Sign In to access the free content across the portals!

Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals

View Subscriptions

Sign in to access the content